A recent meta-analysis, performed on 48 articles published between 1968 and 2012, showed that in patients affected by vitiligo the prevalence of AITD was 14.3%, while positivity to thyroid-specific antibodies [i.e., anti-thyroglobulin (Tg), anti-thyroid peroxidase, and anti-thyrotropin receptor (TSHR)] was found in 20.8% of them (74). The gene discussed is TSHR; the disease is vitiligo.